Threshold Pharmaceuticals, Inc.

( )
THLD PreMarket: $ () as of AM
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards



Health Technology » Biotechnology

Company Profile

Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It develops its product candidates based on hypoxia-activated prodrug technology: evofosfamide and tarloxotinib bromide. It also seeks to optimize patient selectivity for its hypoxia-targeted therapeutics through the development of its [18F]-HX4 investigational hypoxia Positron Emission Tomography tracer. The company was founded by George Francis Tidmarsh and Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, C